Switch to:
Novo Nordisk A/S (NYSE:NVO)
EV/EBIT
21.28 (As of Today)

EV/EBIT ratio is calculated as enterprise value divided by its Earnings Before Interest and Taxes (EBIT). As of today, Novo Nordisk A/S's enterprise value is $142,060 Mil. Novo Nordisk A/S's earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2015 was $6,676 Mil. Therefore, Novo Nordisk A/S's EV/EBIT ratio for today is 21.28.

NVO' s 10-Year EV/EBIT Range
Min: 9.1   Max: 26.8
Current: 21.95

9.1
26.8

During the past 13 years, the highest EV/EBIT Ratio of Novo Nordisk A/S was 26.80. The lowest was 9.10. And the median was 17.30.

NVO's EV/EBITis ranked higher than
60% of the 235 Companies
in the Global Biotechnology industry.

( Industry Median: 26.88 vs. NVO: 21.95 )

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt). Novo Nordisk A/S's enterprise value for the quarter that ended in Jun. 2015 was $0 Mil. Novo Nordisk A/S's earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2015 was $6,676 Mil. Novo Nordisk A/S's Earnings Yield (Joel Greenblatt) for the quarter that ended in Jun. 2015 was %.


Definition

Novo Nordisk A/S's EV/EBIT for today is calculated as:

EV/EBIT=Enterprise Value (Today)/Earnings Before Interest and Taxes (EBIT) (TTM)
=142060.240/6676.37631661
=21.28

Novo Nordisk A/S's current Enterprise Value is $142,060 Mil.
Novo Nordisk A/S's Earnings Before Interest and Taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2015 was 1540.07306474 (Sep. 2014 ) + 1241.40445063 (Dec. 2014 ) + 2050.93250573 (Mar. 2015 ) + 1843.96629552 (Jun. 2015 ) = $6,676 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

This is a more accurate valuation of companies' operation because it consider the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt).

Novo Nordisk A/S's Earnings Yield (Joel Greenblatt) for the quarter that ended in Jun. 2015 is calculated as:

Earnings Yield (Joel Greenblatt) (Q: Jun. 2015 )=EBIT (TTM)/Enterprise Value (Q: Jun. 2015 )
=6676.37631661/0
= %

Novo Nordisk A/S's Enterprise Value for the quarter that ended in Jun. 2015 was $0 Mil.
Novo Nordisk A/S's Earnings Before Interest and Taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2015 was 1540.07306474 (Sep. 2014 ) + 1241.40445063 (Dec. 2014 ) + 2050.93250573 (Mar. 2015 ) + 1843.96629552 (Jun. 2015 ) = $6,676 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Related Terms

Enterprise Value, Earnings Yield (Joel Greenblatt), Earnings Before Interest and Taxes (EBIT)


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Novo Nordisk A/S Annual Data

Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14
ev2ebit 12.6615.4818.6312.6412.2015.2117.8014.1515.8319.76

Novo Nordisk A/S Quarterly Data

Mar13Jun13Sep13Dec13Mar14Jun14Sep14Dec14Mar15Jun15
ev2ebit 13.7712.5514.9015.8320.2320.3821.5919.7624.2621.76
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK